Abstract:Dermatological diseases pose a significant burden on the quality of life of individuals and can be challenging to treat effectively. In this aspect, cannabinoids are gaining increasing importance due to their therapeutic potential in various disease entities including skin diseases. In this synthetic review, we comprehensively analyzed the existing literature in the field of potential dermatological applications of a lesser-known subgroup of cannabinoids, the so-called minor cannabinoids, such as cannabidivarin (CBDV), cannabidiforol (CBDP), cannabichromene (CBC), tetrahydrocannabivarin (THCV), cannabigerolic acid (CBGA), cannabigerol (CBG), cannabielsoin (CBE), cannabimovone (CBM) or cannabinol (CBN), while drawing attention to their unique pharmacological properties. We systematically searched the available databases for relevant studies and analyzed the data to provide an overview of current thematic knowledge. We looked through the full-text, bibliographic and factographic databases, especially Scopus, Web of Science, PubMed, Polish Scientific Journals Database, and selected the most relevant papers. Our review highlights that minor cannabinoids exhibit diverse pharmacological activities, including anti-inflammatory, analgesic, antimicrobial, and anti-itch properties. Several studies have reported their efficacy in mitigating symptoms associated with dermatological diseases such as psoriasis, eczema, acne, and pruritus. Furthermore, minor cannabinoids have shown potential in regulating sebum production, a crucial factor in acne pathogenesis. The findings of this review suggest that minor cannabinoids hold therapeutic promise in the management of dermatological diseases. Further preclinical and clinical investigations are warranted to elucidate their mechanisms of action, determine optimal dosage regimens, and assess long-term safety profiles. Incorporating minor cannabinoids into dermatological therapies could potentially offer novel treatment options of patients and improve their overall well-being.

Cannabidiol in Dermatology: Proposed Mechanism of Action and Potential Medication Interactions

The Potential Role of Cannabidiol in Cosmetic Dermatology: A Literature Review

The potential role of cannabinoids in dermatology

Cannabidiol modulation of immune cell function: in vitro insights and therapeutic implications for atopic dermatitis

Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases

Therapeutic Potential of Minor Cannabinoids in Dermatological Diseases-A Synthetic Review

Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System

Cannabinoids for the Treatment of Hair, Scalp, and Skin Disorders: A Systematic Review

Cannabinoids in the Pathophysiology of Skin Inflammation

Potential of cannabidiol as acne and acne scar treatment: novel insights into molecular pathways of pathophysiological factors

Treatment Advances for Acne Vulgaris: The Scientific Role of Cannabinoids

Molecular and Cellular Mechanisms of Action of Cannabidiol

Exploring Cannabidiol (CBD) and Cannabigerol (CBG) Safety Profile and Skincare Potential

The Modulatory Effects and Therapeutic Potential of Cannabidiol in the Gut

Botanicals in dermatology: an evidence-based review

CBD and THC in Special Populations: Pharmacokinetics and Drug–Drug Interactions

An Overview of Cannabidiol as a Multifunctional Drug: Pharmacokinetics and Cellular Effects

Cannabidiol exerts multitarget immunomodulatory effects on PBMCs from individuals with psoriasis vulgaris

Cannabinoids for the treatment of autoimmune and inflammatory skin diseases: A systematic review

Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH1

Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders